6 Dec 2005 07:00
MINSTER PHARMACEUTICALS plc INTERIM REPORT FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2005 8th December 2005 Cambridge, UK, 6 December 2005 -Minster Pharmaceuticals, the AIM-listed (AIM:MPM) drug development company focused on psychiatric and neurologicaldisorders, confirms that it will be announcing its interim results for the sixmonths ended 30th September 2005 on Thursday 8th December 2005.For further information, please contact: Minster Pharmaceuticals plcDr Paul Sharpe, CEO +44 (0)1799 506623 Northbank Communications +44 (0)207 886 8150Emma Palmer (financial enquiries)Rowan Minnion (media enquiries)ENDMINSTER PHARMACEUTICALS PLC
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Notice of Results
Related Shares
Back to RNS
MPM.L (MPM)
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.